Birchbrook’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.3K Sell
174
-5
-3% -$428 0.01% 180
2026
Q2
$13.8K Hold
179
– – 0.01% 190
2026
Q1
$11.7K Sell
179
-4
-2% -$297 0.01% 188
2025
Q4
$14.5K Sell
183
-118
-39% -$9.04K 0.01% 190
2025
Q3
$22K Sell
301
-26
-8% -$1.91K 0.01% 159
2025
Q2
$24.8K Sell
327
-5
-2% -$354 0.01% 150
2025
Q1
$25.2K Buy
332
+77
+30% +$5.73K 0.01% 141
2024
Q4
$16.8K Buy
255
+15
+6% +$1.05K 0.01% 176
2024
Q3
$16.7K Sell
240
-25
-9% -$1.5K 0.01% 161
2024
Q2
$14K Buy
+265
New +$16.1K 0.01% 179

Other funds holding SOLV

Birchbrook's SOLV Position: Q3 2026 in Review

Birchbrook reduced its Solventum (SOLV) stake by 2.8% in Q3 2026, selling an estimated $428 and leaving 174 shares worth $15.3K. The position accounts for 0.01% of the portfolio, ranked #180.

Birchbrook first reported a position in SOLV in Q2 2024 and has held it in 10 quarters since. The position peaked at $25.2K in Q1 2025. 310 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • Birchbrook held 174 shares of Solventum worth $15.3K as of Q3 2026.
  • Birchbrook sold 5 Solventum shares in Q3 2026, an estimated $428.
  • Solventum made up 0.01% of Birchbrook's portfolio in Q3 2026, its #180 holding.
  • Birchbrook first reported a position in Solventum in Q2 2024 and has held it in 10 quarters since.
  • Birchbrook's Solventum position peaked at $25.2K in Q1 2025.
  • 310 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.